Crossmark

An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B<sub>12</sub> and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity

Crossref DOI link: https://doi.org/10.1136/bmjresp-2014-000061

Published Online: 2014-12-11

Published Print: 2014-12

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Minchom, A R

Saksornchai, K

Bhosle, J

Gunapala, R

Puglisi, M

Lu, S K

Nimako, K

Coward, J

Yu, K C

Bordi, P

Popat, S

O'Brien, M E R
Clinical Trials ^BETA

Clinical trials referenced in this document:

isrctn8734355 at ISRCTN.org

Documents that mention this clinical trial

An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B<sub>12</sub> and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity
https://doi.org/10.1136/bmjresp-2014-000061

Document is current

Any future updates will be listed below